The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Why Translate Bio Shares Are Trading Higher Today
Translate Bio (NASDAQ: TBIO) shares are trading 9.5% higher after Roth Capital Partners raised its price target on the stock from $28 to $45.
Roth Capital Maintains Buy on Translate Bio, Raises Price Target to $45
Roth Capital analyst Tony Butler maintains Translate Bio (NASDAQ:TBIO) with a Buy and raises the price target from $28 to $45.
48 Stocks Moving In Monday’s Mid-Day Session
Gainers
Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The stock is also trading higher in sympathy with the price of Bitcoin.
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 28)